The excellent molecular recognition capabilities of monoclonal antibodies (mAbs) have opened up exciting opportunities for biotherapeutic discovery. Taking advantage of the full potential of this tool necessitates execution of affinity ligands capable of conjugating directly with small molecules to a defined degree of biorthogonality, especially when modifying natural Abs. Herein, a bioorthogonal boronate-affinity-based Ab ligand featuring a 4-(dimethylamino)pyridine and an S-aryl thioester to label full-length Abs is reported. The photoactivatable linker in the acyl donor facilitated purification of azide-labeled Ab (N 3 -Ab) quantitatively cleaved upon brief exposure to UV light while retaining the original Ab activity. Click reactions enabled precise addition of biotin, fluorophore, and a pharmacological agent to the purified N 3 -Abs. The resulting immunoconjugate showed effective cytotoxicity against targeted cells. Bioorthogonal traceless design and reagentless purification allow for this strategy to be a powerful tool to engineer native antibodies amenable to therapeutic intervention.
Investigating a Boronate-Affinity Guided Acylation Reaction for Labelling Native Antibodies.
Chun‐Cheng Lin,Avijit K. Adak,Kuan‐Ting Huang,Chien-Yu Liao,Yuan-Jung Lee,Wen‐Hua Kuo,Yi Huo,Pei‐Jhen Li,Yi-Ju Chen,Bo-Shiun Chen,Yu‐Ju Chen,K. Hwang,Wu Chang
Published 2022 in Chemistry
ABSTRACT
PUBLICATION RECORD
- Publication year
2022
- Venue
Chemistry
- Publication date
2022-02-10
- Fields of study
Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-38 of 38 references · Page 1 of 1
CITED BY
Showing 1-7 of 7 citing papers · Page 1 of 1